Detalhe da pesquisa
1.
Clonal Decomposition and DNA Replication States Defined by Scaled Single-Cell Genome Sequencing.
Cell
; 179(5): 1207-1221.e22, 2019 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31730858
2.
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer.
N Engl J Med
; 384(25): 2394-2405, 2021 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34081848
3.
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY.
Breast Cancer Res Treat
; 204(2): 237-248, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38112922
4.
A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer.
Br J Cancer
; 128(1): 30-41, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36335217
5.
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer.
N Engl J Med
; 382(7): 597-609, 2020 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31825569
6.
Metformin, placebo, and endocrine therapy discontinuation among participants in a randomized double-blind trial of metformin vs placebo in hormone receptor-positive early-stage breast cancer (CCTG MA32).
Breast Cancer Res Treat
; 200(1): 93-102, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37157006
7.
Complementary Medicine Use Amongst Patients with Metastatic Cancer Enrolled in Phase III Clinical Trials.
Oncologist
; 27(3): e286-e293, 2022 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35274718
8.
Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial.
JAMA
; 327(20): 1963-1973, 2022 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35608580
9.
Long-Term Pooled Safety Analysis of Palbociclib in Combination with Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Updated Analysis with up to 5 Years of Follow-Up.
Oncologist
; 26(5): e749-e755, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33486783
10.
Exercise and health-related fitness predictors of chemotherapy completion in breast cancer patients: pooled analysis of two multicenter trials.
Breast Cancer Res Treat
; 188(2): 399-407, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33779887
11.
Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution.
Nature
; 518(7539): 422-6, 2015 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-25470049
12.
Effects of exercise dose and type during breast cancer chemotherapy on longer-term patient-reported outcomes and health-related fitness: A randomized controlled trial.
Int J Cancer
; 146(1): 150-160, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31173341
13.
Higher serum PD-L1 level predicts increased overall survival with lapatinib versus trastuzumab in the CCTG MA.31 phase 3 trial.
Cancer
; 126(22): 4859-4866, 2020 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32910476
14.
Exercise training affects hemodynamics not cardiac function during anthracycline-based chemotherapy.
Breast Cancer Res Treat
; 184(1): 75-85, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32816189
15.
Differential expression and prognostic relevance of autophagy-related markers ATG4B, GABARAP, and LC3B in breast cancer.
Breast Cancer Res Treat
; 183(3): 525-547, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32685993
16.
Treatment effect of palbociclib plus endocrine therapy by prognostic and intrinsic subtype and biomarker analysis in patients with bone-only disease: a joint analysis of PALOMA-2 and PALOMA-3 clinical trials.
Breast Cancer Res Treat
; 184(1): 23-35, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32783178
17.
Patient selection for a developmental therapeutics program using whole genome and Transcriptome analysis.
Invest New Drugs
; 38(5): 1601-1604, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31907737
18.
Impact of Exercise on Chemotherapy Tolerance and Survival in Early-Stage Breast Cancer: A Nonrandomized Controlled Trial.
J Natl Compr Canc Netw
; 18(12): 1670-1677, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33285521
19.
Patterns and predictors of exercise behavior during 24 months of follow-up after a supervised exercise program during breast cancer chemotherapy.
Int J Behav Nutr Phys Act
; 17(1): 23, 2020 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32059728
20.
Efficacy and safety of palbociclib plus endocrine therapy in North American women with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer.
Breast J
; 26(3): 368-375, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31448513